Moreover, RESV downregulated STAT3 in vitro, thereby inhibiting M2-like polarization of tumor-associated macrophages (TAMs) and suppressing the proliferation of LC cells (17). The gene discussed is STAT3; the disease is laryngotracheoesophageal cleft.